Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Sylvester who wrote (1162)	6/23/1998 11:40:00 AM
From: Joe	Read Replies (1) \| Respond to of 4140

With regard to having an LTK system along side a Visx system, I believe you will indeed see it. The doctor who treated my eyes up in Canada had two Visx systems, a Sunrise LTK, and I understand he also has a Nidek system. The LTK system is great for correcting overcorrected PRK myopes, i.e., a myope that has been corrected into hyperopia. While Visx has clinicals ongoing for hyperopia, I do not think they have trials for correcting their overcorrected myopes. By the way these are very unhappy patients and believe me, if the doctor can correct these, he will certainly want to do it rather refering they to another doctor to have LTK performed on the patient. While the LTK at $200K sounds like a lot of money, it is really not that much in the context of a clinic that has already spent half a million on a Visx system. There are a lot of overhead costs with Visx which will not need to be duplicated when an LTK is added to the practice.